跳至主要内容
临床试验/NCT05935657
NCT05935657尚未招募不适用

The Effect of Remimazolam and Dexmedetomidine on the Incidence of Hypotension During Spinal Anesthesia

Pusan National University Yangsan Hospital0 个研究点目标入组 72 人开始时间: 2023年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
入组人数
72
主要终点
Incidence of intraoperative hypotension

研究概览

简要总结

The goal of this clinical trial is to compare the effect of remimazolam and dexmedetomidine on the incidence of hypotension during spinal anesthesia in adult patients.

详细描述

Sedation during spinal anesthesia can reduce the patient's anxiety and increase satisfaction, but sedatives such as dexmedetomidine and midazolam may cause hemodynamic instability such as hypotension and bradycardia. In previous studies , hypotension occurred in about 33% and bradycardia in about 13% during spinal anesthesia, which is related to reduced cardiac output due to sympathetic blockade and relative activation of the parasympathetic nerve.

In the study comparing remimazolam and dexmedetomidine in patients with delirium after orthopedic surgery, the incidence of hypotension was lower in the remimazolam group (10.8%) than in the dexmedetomidine group (39.5%) (p=0.007) and there was no significant difference between the remimazolam group (2.7%) and the dexmedetomidine group (13.2%) in the incidence of bradycardia (p=0.200).

However, the effect of remimazolam on the incidence of hypotension during spinal anesthesia has not been revealed. Therefore, this study is designed to compare the effect of remimazolam and dexmedetomidine on the incidence of hypotension during spinal anesthesia in adults patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Participant, Investigator)

入排标准

年龄范围
19 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient scheduled for surgery under spinal anesthesia, aged 19-79, of ASA class I, II, or III

排除标准

  • Patient refusal
  • Contraindications to regional or neuraxial anesthesia (patient refusal, increased intracranial pressure, infection at puncture site, underlying neurologic disease, severe hypovolemia, severe aortic or mitral stenosis, thrombocytopenia or coagulopathy, sepsis)
  • Contraindications or allergy to dexmedetomidine or remimazolam administration
  • Emergency surgery
  • Pregnancy

研究组 & 干预措施

Remimazolam Group

Experimental

sedation with remimazolam

干预措施: Remimazolam (Drug)

Dexmedetomidine group

Active Comparator

sedation with dexmedetomidine

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

Incidence of intraoperative hypotension

时间窗: Intraoperative period

mean blood pressure lower than 65 mmHg or systolic blood pressure lower than 80% of baseline

次要结局

  • Intraoperative Ramsay sedation scale(Intraoperative period)
  • Incidence of hypoxia(Intraoperative period)
  • Incidence of intraoperative bradycardia(Intraoperative period)
  • Incidence of intraoperative hypertension(Intraoperative period)
  • Incidence of respiratory depression(Intraoperative period)
  • Number of phenylephrine, ephedrine, atropine administered(Intraoperative period)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Gyeong-Jo Byeon, MD, PhD

Associate professor for fund

Pusan National University Yangsan Hospital

相似试验

The Effect of Remimazolam and Dexmedetomidine on the... | 临床试验